|
PMS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62414526272414E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.79536418854332E-14 |
| Normal-vs-Stage2 |
9.80104886139088E-13 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.93978166862507E-12 |
| Stage1-vs-Stage2 |
1.591740E-02 |
| Stage1-vs-Stage3 |
3.050100E-02 |
| Stage1-vs-Stage4 |
3.799900E-02 |
| Stage2-vs-Stage3 |
4.159600E-01 |
| Stage2-vs-Stage4 |
5.363600E-01 |
| Stage3-vs-Stage4 |
8.821600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.0418000047413E-08 |
| Normal-vs-Asian |
1.14360000025293E-07 |
| Caucasian-vs-AfricanAmerican |
9.263400E-01 |
| Caucasian-vs-Asian |
1.941040E-01 |
| AfricanAmerican-vs-Asian |
3.209400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99840144432528E-15 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.997400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63447033685316E-12 |
| Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
| Normal-vs-Age(61-80Yrs) |
1.66555658154266E-12 |
| Normal-vs-Age(81-100Yrs) |
5.90469999999232E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.196300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.135800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.107600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.614800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.678600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.507800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.608300E-02 |
| Classical-VS-Follicular |
1.187210E-01 |
| Classical-VS-Other |
8.271800E-01 |
| Classical-VS-Normal |
5.4582005581949E-11 |
| Tall-VS-Follicular |
4.664400E-01 |
| Tall-VS-Other |
4.055000E-01 |
| Tall-VS-Normal |
3.35980021581861E-10 |
| Follicular-VS-Other |
7.410600E-01 |
| Follicular-VS-Normal |
9.20780118818243E-11 |
| Other-VS-Normal |
2.778700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.75380002029624E-09 |
| N0-vs-N1 |
1.501380E-01 |
|
|
